Tezepelumab for the Treatment of Chronic Spontaneous Urticaria: Results of the Phase 2b INCEPTION Study

By sjmartinez • February 17, 2025

McLaren J, Chon Y, Gorski KS, Bernstein JA, Corren J, Hayama K, Jain V, Lima H, Sofen H, Ponnarambil S, Molfino NA, Maurer M. Tezepelumab for the Treatment of Chronic Spontaneous Urticaria: Results of the Phase 2b INCEPTION Study. J Allergy Clin Immunol. 2025 Feb 14:S0091-6749(25)00172-1. doi: 10.1016/j.jaci.2025.01.045. Epub ahead of print. PMID: 39956278.

Tags: Chronic spontaneous urticaria, Dermatology, INCEPTION, Publications, Tezepelumab, thymic stromal lymphopoietin, TSLP

Dynamics of Th1/Th17 responses and antimicrobial pathways in leprosy skin lesions

Andrade PR, Ma F, Lu J, de Anda J, Lee EY, Agak GW, Dobry CJ, de Andrade Silva BJ, Teles RM, Mansky LA, Perrie J,[...]

Mammary tissue microbiome analysis in PyMT mice reveals Methylobacteria as a commensal organism with potential therapeutic applications

Chan AA, Caron C, Navarrete M, Lee CK, Noguti J, Bui JD, Lee DJ. Mammary tissue microbiome analysis in PyMT mice reveals Methylobacteria as a[...]

Psoriasis

Armstrong AW, Blauvelt A, Callis Duffin K, Huang YH, Savage LJ, Guo L, Merola JF. Psoriasis. Nat Rev Dis Primers. 2025 Jun 26;11(1):45. doi: 10.1038/s41572-025-00630-5.[...]